Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Commercialization Agreement TERMINATION - Owning 100% ...50%/zeusrock

IF IF IF IF IF PTSC get to own 100% of the MMP for this $2m.

This might be a little difficult considering TPL dosn't own the other half of the patents. Chuck Moore is the co owner with PTSC. What may happen if TPL lacks funding to proceed is that Moore and PTSC select another company to pick up the licensing effort.

Steve

Share
New Message
Please login to post a reply